Drug Schedules under the Drugs & Cosmetics Act

Drug Schedules under the Drugs & Cosmetics Act

1. Definition, statutory architecture & scope

• The Drugs Act, 1940 was passed to control the manufacture, sale and distribution of allopathic drugs in India; it was later amended to also cover Ayurvedic, Unani, Siddha and Homoeopathic drugs (Padmaja 7e Ch.5, p.75).
• A 1962 amendment added cosmetics, and the title became the Drugs and Cosmetics Act — under which clear rules were framed for the import, manufacture, sale, labelling and packing of drugs (Padmaja 7e Ch.5, p.75).
• Two-tier legal structure: the Drugs and Cosmetics Act, 1940 (the parent legislation, passed by Parliament) is operationalised by the Drugs and Cosmetics Rules, 1945 (delegated/subordinate legislation, amendable by gazette notification without re-legislating). Most schedules are appended to the Rules, not the Act — hence they can be revised by the central government by notification [D&C Rules].
• A "Schedule" is an annexure to the Rules that groups drugs (or other items) sharing a common regulatory treatment, and prescribes the labelling, prescription, sale, storage and record-keeping obligations that attach to that group [D&C Rules].
• The Act carries two Schedules to the Act itself: the First Schedule (lists the authoritative Ayurveda/Siddha/Unani formulary reference books) and the Second Schedule (standards of quality for imported/manufactured/stocked drugs) [D&C Rules].
• The Rules carry a long alphabetical run of schedules A through Y (with sub-schedules such as C1, F1, M-I/M-II/M-III, P-I) — each governing a distinct facet of the drug life-cycle (forms, fees, biologicals, exemptions, GMP, pharmacy equipment, shelf-life, prescription control, clinical trials, etc.) [D&C Rules].
• Topic scope note: "Drug schedules" here means the Indian D&C Act/Rules schedule system (labelling/prescription/storage/clinical-trial implications) — not the global controlled-substance "scheduling" of the US Controlled Substances Act or the NDPS Act drug lists (the NDPS Act is a separate statute; the D&C schedules only cross-reference it for narcotic/psychotropic labelling) [topic scope].
• Regulators: the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), is the central authority (new-drug approval, clinical-trial permission, imports, Schedule C/C1 & X oversight); State Drug Control Authorities / State Licensing Authorities license manufacture and retail/wholesale sale [CDSCO].